Clinical Trial: A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883.
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A PHASE 1, NON-RANDOMIZED, OPEN-LABEL STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF PF-07817883 IN ADULT PARTICIPANTS WITH RENAL IMPAIRMENT AND HEALTHY ADULT PARTICIPANTS WITH NORMA
Brief Summary:
The purpose of the study is to learn about:how PF-07817883 is processed in the body of adult participants.the safety of PF-07817883.These participants will have different levels of kidney function loss:moderateseverenone or healthy Participants with moderate, severe or no loss of kidney function may be taken into one of 3 groups.This study is seeking for participants who:are male or female of 18 to 90 years of age.have different levels of damage to kidney function or for one of the groups, no damageare willing to…
Read more